We would like to take advantage of the latest patch of GRCh38, but we also want to use the no alt analysis set. From the FTP links on the GRC site, I can only see the "analysis_set" versions for the base GRCh38, not the patched versions. Is anybody else using patched no alt (or other analysis set versions)? If so, how are you doing it?
Sidebar: more general question: of all of the versions/flavors avaliable, what are people using?
So far, I've thought of:
1. Downloading the patched version and manually removing sequences I don't want and renaming to chr1, chr2, etc. The problem is that this doesn't get me the same masking as no alt, and I'm concerned of the possibility of doing something differently than the norm, which can cause problems if we're processing BAMs from somewhere else.
2. Create an actual patch file by diffing the base and patched version, and apply that patch to the no alt.
Both of these feel very wrong, and I'm thinking there has to be a best practice (or at least a better one).
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
Latest Articles
Collapse
-
by seqadmin
During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.
Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...-
Channel: Articles
09-09-2024, 10:59 AM -
-
by seqadmin
The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...-
Channel: Articles
08-27-2024, 04:44 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, Today, 02:44 PM
|
0 responses
8 views
0 likes
|
Last Post
by seqadmin
Today, 02:44 PM
|
||
Started by seqadmin, 09-06-2024, 08:02 AM
|
0 responses
143 views
0 likes
|
Last Post
by seqadmin
09-06-2024, 08:02 AM
|
||
Started by seqadmin, 09-03-2024, 08:30 AM
|
0 responses
150 views
0 likes
|
Last Post
by seqadmin
09-03-2024, 08:30 AM
|
||
Started by seqadmin, 08-27-2024, 04:40 AM
|
0 responses
158 views
0 likes
|
Last Post
by seqadmin
08-27-2024, 04:40 AM
|